HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Structural basis for binding of cyclic 2-oxoglutarate analogues to factor-inhibiting hypoxia-inducible factor.

Abstract
Aromatic analogues of the 2-oxoglutarate co-substrate of the hypoxia-inducible factor hydroxylases are shown to bind at the active site iron: Pyridine-2,4-dicarboxylate binds as anticipated with a single molecule chelating the iron in a bidentate manner. The binding mode of a hydroxamic acid analogue, at least in the crystalline state, is unusual because two molecules of the inhibitor are observed at the active site and partial displacement of the iron binding aspartyl residue was observed.
AuthorsAna Conejo-Garcia, Michael A McDonough, Christoph Loenarz, Luke A McNeill, Kirsty S Hewitson, Wei Ge, Benoît M Liénard, Christopher J Schofield, Ian J Clifton
JournalBioorganic & medicinal chemistry letters (Bioorg Med Chem Lett) Vol. 20 Issue 20 Pg. 6125-8 (Oct 15 2010) ISSN: 1464-3405 [Electronic] England
PMID20822901 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2010 Elsevier Ltd. All rights reserved.
Chemical References
  • Ketoglutaric Acids
  • Repressor Proteins
  • Mixed Function Oxygenases
  • HIF1AN protein, human
Topics
  • Binding Sites
  • Catalytic Domain
  • Humans
  • Ketoglutaric Acids (chemistry, pharmacology)
  • Mixed Function Oxygenases
  • Models, Molecular
  • Protein Binding
  • Repressor Proteins (chemistry, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: